Original Article
European Journal of Clinical Nutrition (2009) 63, 536–542; doi:10.1038/ejcn.2008.6; published online 13 February 2008
Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study
Guarantors: JWR Twisk and MT Driessen.
Contributors: MTD contributed to the manuscript and data analysis; LLJK contributed to the manuscript, study design, data collection and project planning; LV contributed to the manuscript and data analysis; DS contributed to the manuscript and data collection; JWRT contributed to the manuscript, study design, data analysis and coordinated the project.
M T Driessen1, L L J Koppes1, L Veldhuis1,2,3, D Samoocha1 and J W R Twisk2,4
- 1Department of Public and Occupational Health, EMGO Institute, VU University Medical Center, Amsterdam, The Netherlands
- 2Faculty of Earth and Life Science, Institute of Health Sciences, Vrije Universiteit, Amsterdam, The Netherlands
- 3Department of Public Health, Erasmus MC—University Medical Center Rotterdam, Rotterdam, The Netherlands
- 4Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
Correspondence: Professor Dr JWR Twisk, Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, PO Box 7057, Amsterdam 1007 MB, The Netherlands. E-mail: jwr.twisk@vumc.nl
Received 12 June 2007; Revised 18 December 2007; Accepted 2 January 2008; Published online 13 February 2008.
Abstract
Background/Objectives:
Coffee consumption has been postulated to decrease the risk of diabetes mellitus type II. The long-term effects of coffee consumption on the metabolic syndrome (MS) and its components are unknown. This study investigated the relationship of long-term coffee consumption between the age of 27 and 36 years with the prevalence of the MS at the age of 36 years.
Subject/Methods:
Data on coffee consumption and the MS components were derived from a healthy sample of 174 men and 194 women followed up from the age of 27 years onwards. Data analysis was performed with the use of generalized estimating equations and regression analysis.
Results:
At the age of 36 years, the prevalence of the MS was 10.1%. The growth of coffee consumption did not differ significantly between subjects with or without the MS or its components. Regression analyses showed that one cup day-1 higher coffee consumption was related to 0.11 mm Hg lower mean arterial blood pressure (P=0.03), 0.02 mg 100 ml-1 higher triglyceride level (P=0.57), 0.04 mg 100 ml-1 higher high-density lipoprotein cholesterol level (P=0.35), 0.09% higher HbA1c (P=0.12) and 0.02 cm larger waist circumference (P=0.57). After adjustment for physical activity, energy intake, smoking behaviour and alcohol consumption, none of the relationships between coffee consumption and the MS or its components was significant.
Conclusions:
Coffee consumption is not associated with the MS or its components in a healthy sample followed up for 9 years.
Keywords:
metabolic syndrome, coffee consumption, risk components, healthy sample
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Which are the greatest recent discoveries and the greatest future challenges in nutrition?
European Journal of Clinical Nutrition Review
RESEARCH
Are there associations between coffee consumption and glucose tolerance in elderly subjects?
European Journal of Clinical Nutrition Original Article
American Journal of Hypertension Original Article
International Journal of Obesity Original Article
Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects
European Journal of Clinical Nutrition Original Article
